Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Butterfly Network, Inc. (BFLY) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Devices
$5.54
-0.14 (-2.46%)Did BFLY Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Butterfly Network is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, BFLY has a bullish consensus with a median price target of $5.75 (ranging from $5.25 to $6.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $5.54, the median forecast implies a 3.8% upside. This outlook is supported by 5 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Joshua Jennings at TD Cowen, projecting a 8.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for BFLY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 2, 2026 | Freedom Broker | Ilya Zubkov | Buy | Maintains | $5.50 |
| Feb 27, 2026 | TD Cowen | Joshua Jennings | Buy | Maintains | $6.00 |
| Jan 20, 2026 | Lake Street | Buy | Maintains | $N/A | |
| Dec 31, 2025 | Freedom Broker | Buy | Initiates | $N/A | |
| Dec 31, 2025 | Freedom Capital Markets | Ilya Zubkov | Buy | Initiates | $5.00 |
| Jul 1, 2025 | Craig-Hallum | Buy | Initiates | $N/A | |
| May 5, 2025 | Lake Street | Buy | Maintains | $N/A | |
| Mar 17, 2025 | William Blair | Outperform | Initiates | $N/A | |
| Sep 10, 2024 | Lake Street | Buy | Initiates | $N/A | |
| Mar 29, 2023 | UBS | Neutral | Initiates | $N/A | |
| Nov 29, 2022 | Oppenheimer | Outperform | Initiates | $N/A | |
| Oct 4, 2022 | B. Riley Securities | Buy | Initiates | $N/A | |
| Dec 17, 2021 | UBS | Neutral | Initiates | $N/A | |
| Jun 21, 2021 | Cowen & Co. | Outperform | Initiates | $N/A |
The following stocks are similar to Butterfly Network based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Butterfly Network, Inc. has a market capitalization of $1.47B with a P/E ratio of -18.2x. The company generates $102.92M in trailing twelve-month revenue with a -73.6% profit margin.
Revenue growth is +25.0% quarter-over-quarter, while maintaining an operating margin of -50.8% and return on equity of -35.2%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides handheld ultrasound imaging solutions.
The company generates revenue by selling portable ultrasound devices and related software to healthcare providers. Its products are designed to be integrated into clinical workflows, enabling clinicians to perform imaging directly at the point of care. This approach not only enhances the accessibility of ultrasound technology but also supports a variety of medical assessments and treatment decisions.
Butterfly Network is headquartered in Burlington, Massachusetts, and its innovative imaging solutions are utilized across diverse healthcare environments, including hospitals and outpatient clinics, where quick and portable imaging capabilities can significantly impact patient care.
Healthcare
Medical Devices
220
Mr. Joseph M. DeVivo
United States
2020
Butterfly Network, Inc. (NYSE: BFLY) will participate in the TD Cowen Medical Devices Emerging Growth Call on June 18, 2026, with key executives presenting.
Butterfly Network's participation in a prominent medical devices event highlights its growth prospects and innovation, potentially influencing investor sentiment and stock performance.
Butterfly Network, Inc. (BFLY) presented at the 46th Annual William Blair Growth Stock Conference, sharing insights and updates relevant to investors.
Butterfly Network's presentation may indicate growth potential or strategic plans, impacting investor sentiment and stock performance based on market reactions and future expectations.
Butterfly Network, Inc. (BFLY) and American Well Corporation (AMWL) have been compared to their sector's performance year-to-date. Further details on performance metrics were not provided.
Performance comparisons reveal relative strength or weakness of BFLY and AMWL against their sector, influencing investor sentiment and potential investment decisions.
Butterfly Network (NYSE: BFLY) will present at the William Blair 46th Annual Growth Stock Conference on June 4, 2026, at 8:40 AM CT, with one-on-one investor meetings scheduled.
Butterfly Network's participation in the conference highlights its visibility to investors, potential for growth, and opportunities for direct engagement, which can influence stock performance and investor sentiment.
Butterfly Network, Inc. (BFLY) presented prepared remarks at the Bank of America Global Healthcare Conference, highlighting its strategic initiatives and future outlook.
Butterfly Network's presentation at a major healthcare conference signals potential growth opportunities and strategic developments, influencing investor sentiment and stock performance.
Butterfly Network, Inc. (BFLY) and American Well Corporation (AMWL) have shown performance metrics relative to their sector in 2023, indicating sector-specific trends.
Performance comparisons highlight BFLY and AMWL's relative strength or weakness in their sector, influencing investor sentiment and potential stock movements.
Based on our analysis of 3 Wall Street analysts, Butterfly Network, Inc. (BFLY) has a median price target of $5.75. The highest price target is $6.00 and the lowest is $5.25.
According to current analyst ratings, BFLY has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.54. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict BFLY stock could reach $5.75 in the next 12 months. This represents a 3.8% increase from the current price of $5.54. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by selling portable ultrasound devices and related software to healthcare providers. Its products are designed to be integrated into clinical workflows, enabling clinicians to perform imaging directly at the point of care. This approach not only enhances the accessibility of ultrasound technology but also supports a variety of medical assessments and treatment decisions.
The highest price target for BFLY is $6.00 from Joshua Jennings at TD Cowen, which represents a 8.3% increase from the current price of $5.54.
The lowest price target for BFLY is $5.25 from at , which represents a -5.2% decrease from the current price of $5.54.
The overall analyst consensus for BFLY is bullish. Out of 3 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $5.75.
Stock price projections, including those for Butterfly Network, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.